Survival, haemodynamics and cardiac remodelling follow up in mice after myocardial infarction

Clinical and Experimental Pharmacology and Physiology

Volumn 30, Issue 1-2, 2003, Pages 25-31

  Pons, S ^a   Fornes, P ^a   Hagege, A A ^a   Heudes, D ^a   Giudicelli, J F ^a   Richer, C ^a  

^a INSERM   (France)

Author keywords

Cardiac function; Echocardiography; Left ventricular morphology; Mortality; Mouse; Myocardial infarction

Indexed keywords

COLLAGEN;

ANIMAL EXPERIMENT; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; HEART DILATATION; HEART EJECTION FRACTION; HEART FUNCTION; HEART HEMODYNAMICS; HEART INFARCTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE MASS; HEART VENTRICLE REMODELING; HEART WEIGHT; ISCHEMIC HEART DISEASE; MALE; MOUSE; NONHUMAN; SURVIVAL; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 0037283691     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.2003.03784.x     Document Type: Article

References (26)

1. Anversa P, Beghi C, Kikkawa Y, Olivetti G. Myocardial infarction in rats. Infarct size, myocyte hypertrophy, and capillary growth. Circ. Res. 1986; 58: 26-37.
2. Pfeffer MA, Pfeffer JM, Fishbein MC et al. Myocardial infarct size and ventricular function in rats. Circ. Res. 1979; 44: 503-12.
3. Pfeffer MA, Pfeffer JM, Steinberg C, Finn P. Survival after an experimental myocardial infarction: Beneficial effects of long-term therapy with captopril. Circulation 1985; 72: 406-12.
4. 1 receptor blockade on survival, haemodynamics and cardiac remodeling in chronic heart failure in rats. Cardiovasc. Res. 1999; 41: 100-8.
5. Richer C, Mulder P, Fornes P, Domergue V, Heudes D, Giudicelli JF. Long-term treatment with trandolapril opposes cardiac remodeling and prolongs survival after myocardial infarction in rats. J. Cardiovasc. Pharmacol. 1992; 20: 147-56.
6. Sweet CS, Emmert SE, Stabilito II, Ribeiro LGT. Increased survival in rats with congestive heart failure treated with enalapril. J. Cardiovasc. Pharmacol. 1987; 10: 636-42.
7. Mulder P, Richard V, Derumeaux G et al. Role of endogenous endothelin in chronic heart failure: Effect of long term treatment with an endothelin antagonist on survival, haemodynamics, and cardiac remodeling. Circulation 1997; 96: 1976-82.
8. Mulder P, Richard V, Compagnon P et al. Increased survival after long treatment with mibefradil, a selective T-channel calcium antagonist, in heart failure. J. Am. Coll. Cardiol. 1997; 29: 416-21.
9. Gao XM, Dart AM, Dewar E, Jennings G, Du XJ. Serial echocardiographic assessment of left ventricular dimensions and function after myocardial infarction in mice. Cardiovasc. Res. 2000; 45: 330-8.
10. Lutgens E, Daemen MJAP, De Muinck ED, Debets J, Leenders P, Smits JFM. Chronic myocardial infarction in the mouse: Cardiac structural and functional changes. Cardiovasc. Res. 1999; 41: 586-93.
11. Patten RD, Aronovitz MJ, Deras-Mejia L et al. Ventricular remodeling in a mouse model of myocardial infarction. Am. J. Physiol. 1998; 274: H1812-20.
12. 1 antagonist, and combined treatment in mice with heart failure. J. Cardiovasc. Pharmacol. 2000; 36: 472-80.
13. Hwang MW, Matsumori A, Furukawa Y et al. Neutralization of interleukin-1β in the acute phase of myocardial infarction promotes the progression of left ventricular remodeling. J. Am. Coll. Cardiol. 2001; 38: 1546-53.
14. Michael LH, Entman ML, Hartley CJ et al. Myocardial ischemia and reperfusion: A murine model. Am. J. Physiol. 1995; 269: H2147-54.
15. Richer C, Domergue V, Gervais M, Bruneval P, Giudicelli JF. Fluospheres for cardiovascular phenotyping genetically modified mice. J. Cardiovasc. Pharmacol. 2000; 36: 396-404.
16. Fornes P, Richer C, Pussard E, Heudes D, Domergue V, Giudicelli JF. Beneficial effects of trandolapril on experimentally induced congestive heart failure in rats. Am. J. Cardiol. 1992; 70: 43D-51D.
17. Schiller NB, Shah PM, Crawford Metal. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J. Am. Soc. Echocardiogr. 1989; 2: 358-67.
18. Brocheriou V, Hagege AA, Oubenaissa A et al. Cardiac functional improvement by a human Bcl-2 transgene in a mouse model of ischemia/reperfusion injury. J. Gene Med. 2000; 2: 326-33.
19. Ceiler DL, Smits JFM, Ghostine S, Alhenc-Gelas F, Meneton P, Hagege AA. Influence of tissue kallikrein on post-infarction cardiac changes: A knock-out mouse study. Circulation 2000; 102: II-28 (Abstract).
20. Mantel N. Chi-square tests with one degree of freedom: Extension of the Mantel-Haenszel procedure. J. Am. Stat. Assoc. 1963; 58: 690-700.
21. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; i: 307-10.
22. Komamura K, Shannon RP, Ihara T et al. Exhaustion of Frank-Starling mechanism in conscious dogs with heart failure. Am. J. Physiol. 1993; 265: H1119-31.
23. Yang XP, Liu YH, Rhaleb NE, Kurihara N, Kim HE, Carretero OA. Echocardiographic assessment of cardiac function in conscious and anesthetized mice. Am. J. Physiol. 1999; 277: H1967-74.
24. 1-receptor blockade on coronary dynamics, function, and structure in postischemic heart failure in rats. J. Cardiovasc. Pharmacol. 2000; 36: 329-37.
25. Sanbe A, Takeo S. Long-term treatment with angiotensin I-converting enzyme inhibitors attenuated the loss of cardiac β-adrenoceptor responses in rats with chronic heart failure. Circulation 1995; 92: 2666-75.
26. Michel JB, Lattion AL, Salzmann JL et al. Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction. Circ. Res. 1988; 62: 641-50.